About SignalPath
SignalPath is a Healthcare company based in Durham (United States) founded in 2014, and was acquired by Verily in August 2021. Cloud-based software solutions for clinical research sites are provided. SignalPath has raised $35.64 million across 5 funding rounds from investors including Verily. SignalPath offers products and services including Site CTMS, Digital Protocols, and Platform Workbench. Its focus areas include HealthTech, Life Sciences Tech, Diversified and Life Sciences. Its competitors include Veeva Systems, Instem and Strateos; 2 of its 3 listed competitors have raised funding.
Company details
SignalPath was founded in 2014 in Durham, United States, focusing on the clinical research sector. Software solutions are developed for research sites, featuring cloud-based, HIPAA-compliant tools that ensure interoperability across devices and allow customization. Workflow management, document and data storage, communication features, financial and budgeting tools, and payment systems are included. The platform is currently offered in beta version.
- Headquarters Durham, United States
- Stage Acquired
- SectorsHealthcare
- Website signalpath.com
- Social LinkedIn
- Acquired by Verily (Aug 2021)
Products & Services of SignalPath
SignalPath offers a comprehensive portfolio of products and services, including Site CTMS, Digital Protocols, and Platform Workbench.
Advanced system for digitizing protocols and streamlining research workflows.
Converts PDF protocols into dynamic digital models for efficient data handling.
Collaborative tool for multimodal data analytics in healthcare applications.
Funding Insights of SignalPath
SignalPath has successfully raised a total of $35.64M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $18.18 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $35.64M
- Total Rounds 5
- Last Round Series B — $18.18M
- First Round $1.5M
(Jun 2015)
All 5 funding rounds of SignalPath with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2019 | $18.18M | Series B | – | – | – |
| Jan 2018 | $8M | Series A | – | – | – |
| Jan 2017 | $5M | Series A | – | – | – |
| Feb 2016 | $2.96M | Seed | – | – | – |
| Jun 2015 | $1.5M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in SignalPath
SignalPath has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Verily.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AI-based solutions for health management are provided. | 2015 | verily.com | Dallas, United States |
Investor details for SignalPath
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SignalPath
239 people are tracked at SignalPath (68 in leadership, 3 in board & advisors, 168 in team).
| Name | Role | Group |
|---|---|---|
Sam Kavusi | Head Of Retina Imaging And Telerential Integration | Leadership |
Ben Schriesheim | Head Of Platform UX | Leadership |
Christopher Girardi | Head Of Performance Marketing | Leadership |
Celia G. Carter | Head Of Product Management, Research Solutions | Leadership |
Erik Lack | Head Of Participant UX | Leadership |
Alix Hart | Chief Marketing Officer | Leadership |
Rakesh Yelugoila | Head Of CRM | Leadership |
Bob Purcell | Head Of Communications | Leadership |
Carolyn Bradner Jasik | Associate Chief Clinical Officer | Leadership |
Sharib Haroon | Director Finance ( Commercial & Product ) | Leadership |
Sherwin Sheik | Head Of Business Operations | Leadership |
Sabrina Rohatgi | Head Of Strategy & Legal Operations | Leadership |
Hanan Butler | Head Of Product, Clinical Trials | Leadership |
Stephen Gillett | CEO | Leadership |
Scott Burke | CTO | Leadership |
Utpal Koppikar | CFO | Leadership |
Ryan Miller | Head Of Corporate Marketing | Leadership |
Zita Netzel | Head, Central Hardware Engineering | Leadership |
William Marks, Jr | Head, Clinical Science & Head of Neurology | Leadership |
Matthew Tobelmann | Director Of Business Operations | Leadership |
219 more people are available in the full profile.
Complete people profiles for SignalPath
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SignalPath
4 dated milestones of SignalPath across 7 years, from founding to its latest funding, stage changes and deals.
- Founded SignalPath is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series B, of $18.2M.
- Exit Acquired by Verily.
Competitors of SignalPath
SignalPath has 3 listed competitors in our database, 2 of them funded. They include Veeva Systems, Instem and Strateos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| veeva.com | 2007 | Pleasanton, United States | $4M | 226 | Cloud-based data management solutions for healthcare are provided. | |
| instem.com | 1969 | Conshohocken, United States | 190 | Software for life science data collection and analysis is provided. | ||
| strateos.com | 2019 | Menlo Park, United States | $72.6M | 147 | Provider of cloud based platform provides data driven information for biotech research |
Detailed competitors of SignalPath
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as SignalPath (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Signalpath
Complete news archive for SignalPath
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SignalPath
SignalPath was founded in 2014 and raised its 1st funding round 1 year after it was founded.
SignalPath is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
SignalPath is a funded company, having raised a total of $35.64M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Jun 2015.
SignalPath was founded in 2014 in Durham, United States, focusing on the clinical research sector. Software solutions are developed for research sites, featuring cloud-based, HIPAA-compliant tools that ensure interoperability across devices and allow customization. Workflow management, document and data storage, communication features, financial and budgeting tools, and payment systems are included. The platform is currently offered in beta version.
SignalPath's top competitors include Veeva Systems, Instem and Strateos.
SignalPath offers Site CTMS, Digital Protocols, and Platform Workbench.
SignalPath has 1 investor. Key investors include Verily.
Yes. SignalPath was acquired by Verily in August 2021.